Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

A multi-marker molecular signature approach for treatment-specific subgroup identification with survival outcomes.

Li L, Guennel T, Marshall S, Cheung LW.

Pharmacogenomics J. 2014 Mar 18. doi: 10.1038/tpj.2014.9. [Epub ahead of print]

PMID:
24637498
[PubMed - as supplied by publisher]
2.

Updating Systematic Reviews.

Shojania KG, Sampson M, Ansari MT, Ji J, Garritty C, Rader T, Moher D.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Sep.

PMID:
20734512
[PubMed]
Books & Documents
3.
4.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
[PubMed - indexed for MEDLINE]
5.

Guidelines, editors, pharma and the biological paradigm shift.

Singh AR, Singh SA.

Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176.

PMID:
22058616
[PubMed]
Free PMC Article
6.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

PMID:
11701102
[PubMed - indexed for MEDLINE]
Free Article
7.

Information management to enable personalized medicine: stakeholder roles in building clinical decision support.

Downing GJ, Boyle SN, Brinner KM, Osheroff JA.

BMC Med Inform Decis Mak. 2009 Oct 8;9:44. doi: 10.1186/1472-6947-9-44.

PMID:
19814826
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(25):1-49. Epub 2010 Dec 1.

PMID:
23074403
[PubMed]
Free PMC Article
9.

Realizing the promise of personalized medicine.

Aspinall MG, Hamermesh RG.

Harv Bus Rev. 2007 Oct;85(10):108-17, 165.

PMID:
17972499
[PubMed - indexed for MEDLINE]
10.

Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.

Lipkovich I, Dmitrienko A.

J Biopharm Stat. 2014;24(1):130-53. doi: 10.1080/10543406.2013.856024.

PMID:
24392982
[PubMed - in process]
11.

Toward theragnostics.

Pene F, Courtine E, Cariou A, Mira JP.

Crit Care Med. 2009 Jan;37(1 Suppl):S50-8. doi: 10.1097/CCM.0b013e3181921349. Review.

PMID:
19104225
[PubMed - indexed for MEDLINE]
12.

Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).

Foffi G, Pastore A, Piazza F, Temussi PA.

Phys Biol. 2013 Aug 2;10(4):040301. [Epub ahead of print]

PMID:
23912807
[PubMed - as supplied by publisher]
13.

Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.

Paciorek CJ, Liu Y; HEI Health Review Committee.

Res Rep Health Eff Inst. 2012 May;(167):5-83; discussion 85-91.

PMID:
22838153
[PubMed - indexed for MEDLINE]
14.

Personalized medicine: a paradigm for a sustainable pharmaceutical industry?

Chackalamannil S, Desai MC.

Curr Opin Drug Discov Devel. 2009 Jul;12(4):443-5.

PMID:
19562640
[PubMed - indexed for MEDLINE]
16.

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Johnson SK, Heuck CJ, Albino AP, Qu P, Zhang Q, Barlogie B, Shaughnessy JD Jr.

Int J Hematol. 2011 Oct;94(4):321-33. doi: 10.1007/s12185-011-0948-y. Epub 2011 Oct 15. Review.

PMID:
22002477
[PubMed - indexed for MEDLINE]
17.

Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.

Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R.

PLoS Comput Biol. 2013;9(3):e1002975. doi: 10.1371/journal.pcbi.1002975. Epub 2013 Mar 21.

PMID:
23555212
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
[PubMed - indexed for MEDLINE]
19.

A Bayesian approach to subgroup identification.

Berger JO, Wang X, Shen L.

J Biopharm Stat. 2014;24(1):110-29. doi: 10.1080/10543406.2013.856026.

PMID:
24392981
[PubMed - in process]
20.

Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures.

Alshalalfa M, Alhajj R.

BMC Bioinformatics. 2013;14 Suppl 12:S1. doi: 10.1186/1471-2105-14-S12-S1. Epub 2013 Sep 24.

PMID:
24267745
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk